Which drug is most likely to interact with treprostinil due to its antiplatelet effects?

Which drug is most likely to interact with treprostinil due to its antiplatelet effects?

• A. Glyburide
• B. Warfarin
• C. Cyclospirine
• D. Albuterol

Answer: (B)

Treprostinil is a prostacyclin analog used primarily in the management of pulmonary arterial hypertension. It acts as a potent vasodilator and has antiplatelet effects. Warfarin, an anticoagulant, works by inhibiting vitamin K epoxide reductase and affects the synthesis of clotting factors, ultimately leading to a decreased ability of blood to clot. The interaction between treprostinil and warfarin is significant because both medications influence hemostasis. Warfarin's anticoagulant effects can be enhanced in the presence of treprostinil, potentially increasing the risk of bleeding. This is particularly relevant in patients who are receiving both therapies, as careful monitoring of coagulation parameters (like INR) may become necessary to avoid complications. In contrast, glyburide is primarily an oral hypoglycemic medication and does not exert antiplatelet effects. Cyclosporine is an immunosuppressant which can interact with various drugs but does not directly affect platelet function in the context of treprostinil. Albuterol, a bronchodilator, is used to treat asthma and has no significant impact on platelet function or coagulation profiles. Thus, warfarin is the drug most likely to interact with treprost

Treprostinil is a prostacyclin analog used primarily in the management of pulmonary arterial hypertension. It acts as a potent vasodilator and has antiplatelet effects. Warfarin, an anticoagulant, works by inhibiting vitamin K epoxide reductase and affects the synthesis of clotting factors, ultimately leading to a decreased ability of blood to clot.

The interaction between treprostinil and warfarin is significant because both medications influence hemostasis. Warfarin's anticoagulant effects can be enhanced in the presence of treprostinil, potentially increasing the risk of bleeding. This is particularly relevant in patients who are receiving both therapies, as careful monitoring of coagulation parameters (like INR) may become necessary to avoid complications.

In contrast, glyburide is primarily an oral hypoglycemic medication and does not exert antiplatelet effects. Cyclosporine is an immunosuppressant which can interact with various drugs but does not directly affect platelet function in the context of treprostinil. Albuterol, a bronchodilator, is used to treat asthma and has no significant impact on platelet function or coagulation profiles. Thus, warfarin is the drug most likely to interact with treprost